What is NDC 55154-8335?

55154-8335 is the product NDC for Mirtazapine, Mirtazapine 15 mg/1 tablet, orally disintegrating, listed with the FDA by Cardinal Health 107, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Cardinal Health 107, LLC, NDC labeler code 55154. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Mirtazapine?

138 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Mirtazapine NDC 55154-8335 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)55154-8335Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55154-8335Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
55154-8335-6	55154833506	1 BLISTER PACK in 1 BAG (55154-8335-6) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACKMarketed from Dec 8, 2005

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Mirtazapine
Generic name (nonproprietary): mirtazapine
Active ingredients: Mirtazapine — 15 mg/1
Dosage form: Tablet, Orally disintegrating
Route: Oral
Labeler: Cardinal Health 107, LLCNDC labeler code 55154
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077376
Marketing start: Dec 8, 2005
Listing expires: Dec 31, 2026
Identifiers: Product ID 55154-8335_8c99c382-530d-428d-8172-710b3ab71e83SPL ID 8c99c382-530d-428d-8172-710b3ab71e83SPL set ID 5127517f-b8d0-4af1-8a2f-5225719600bcRxCUI 283406UNII A051Q2099QUPC 0055154833561

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N455154833506 followed by a unit qualifier and the quantity

Package 55154-8335-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 21, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Mirtazapine orally disintegrating tablets are indicated for the treatment of major depressive disorder (MDD) in adults [see Clinical Studies (14) ]. Mirtazapine orally disintegrating tablets are indicated for the treatment of major depressive disorder (MDD) in adults. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 55154-8335

What is NDC 55154-8335?: 55154-8335 is the product NDC for Mirtazapine, Mirtazapine 15 mg/1 tablet, orally disintegrating, listed with the FDA by Cardinal Health 107, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Mirtazapine.
What is the active ingredient?: Mirtazapine.
Who is the labeler?: Cardinal Health 107, LLC, NDC labeler code 55154. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Mirtazapine?: 138 other product NDCs are listed under this name. See all Mirtazapine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Mirtazapine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Mirtazapine	Mirtazapine 15 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-0319	67046-0319-03
Mirtazapine	Mirtazapine 15 mg/1	Tablet, Film coatedOral	Cardinal Health 107, LLC	55154-0280	55154-0280-00
Mirtazapine	Mirtazapine 7.5 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-0625	67046-0625-03
Mirtazapine	Mirtazapine 45 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-2024	67046-2024-03
Mirtazapine	Mirtazapine 7.5 mg/1	Tablet, Film coatedOral	NCS HealthCare of KY, LLC dba Vangard Labs	0615-8663	00615-8663-0500615-8663-39
Mirtazapine	Mirtazapine 7.5 mg/1	Tablet, Film coatedOral	ANI Pharmaceuticals, Inc.	70954-830	70954-0830-10
Mirtazapine	Mirtazapine 30 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-0484	67046-0484-03
Mirtazapine	Mirtazapine 30 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-0068	67046-0068-03
Mirtazapine	Mirtazapine 30 mg/1	Tablet, Film coatedOral	Safecor Health LLC	48433-077	48433-0077-20
Mirtazapine	Mirtazapine 15 mg/1	Tablet, Film coatedOral	Safecor Health LLC	48433-076	48433-0076-20

All 139 Mirtazapine NDCs

Other NDCs under ANDA 077376

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 077376
Product	Strength	Form · route	Labeler	Product NDC
Mirtazapine	Mirtazapine 15 mg/1	Tablet, Orally disintegratingOral	Rising Pharma Holdings, Inc.	57237-011
Mirtazapine	Mirtazapine 30 mg/1	Tablet, Orally disintegratingOral	Rising Pharma Holdings, Inc.	57237-012
Mirtazapine	Mirtazapine 45 mg/1	Tablet, Orally disintegratingOral	Rising Pharma Holdings, Inc.	57237-013
Mirtazapine	Mirtazapine 15 mg/1	Tablet, Orally disintegratingOral	Aurobindo Pharma Limited	65862-021
Mirtazapine	Mirtazapine 45 mg/1	Tablet, Orally disintegratingOral	Aurobindo Pharma Limited	65862-023
Mirtazapine	Mirtazapine 30 mg/1	Tablet, Orally disintegratingOral	Bryant Ranch Prepack	71335-2978